Cargando…

Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda

Ceftriaxone has a high propensity for misuse because of its high rate of utilization. In this study, we aimed at assessing the appropriateness of the clinical utilization of ceftriaxone in nine health facilities in Uganda. Using the World Health Organization (WHO) Drug Use Evaluation indicators, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutyabami, Paul, Munanura, Edson Ireeta, Kalidi, Rajab, Balikuna, Sulah, Ndagire, Margaret, Kaggwa, Bruhan, Nambatya, Winnie, Kamba, Pakoyo Fadhiru, Musiimenta, Allan, Kesi, Diana Nakitto, Nambasa, Victoria, Serwanga, Allan, Ndagije, Helen Byomire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300672/ https://www.ncbi.nlm.nih.gov/pubmed/34202391 http://dx.doi.org/10.3390/antibiotics10070779

Ejemplares similares

Threats posed by stockpiles of expired pharmaceuticals in low- and middle-income countries: a Ugandan perspective
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2017)

Why regulatory indifference towards pharmaceutical pollution of the environment could be a missed opportunity in public health protection. a holistic view
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2017)

The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda
por: Rajab, Kalidi, et al.
Publicado: (2023)

Application of the herbal chemical marker ranking system (Herb MaRS) to the standardization of herbal raw materials: a case study
por: Kaggwa, Bruhan, et al.
Publicado: (2023)

Safety and Efficacy of Medicinal Plants Used to Manufacture Herbal Products with Regulatory Approval in Uganda: A Cross-Sectional Study
por: Kaggwa, Bruhan, et al.
Publicado: (2022)

Predictors of controlled prescription drug non-medical and lifetime use among patients accessing public mental health services in Uganda: a cross-sectional study
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2021)

Ethnobotanical Survey of Medicinal Plants Used in Breast Cancer Treatment by Traditional Health Practitioners in Central Uganda
por: Lutoti, Stephen, et al.
Publicado: (2023)

Chemometric Classification of Mangifera indica L. Leaf Cultivars, Based on Selected Phytochemical Parameters; Implications for Standardization of the Pharmaceutical Raw Materials
por: Kaggwa, Bruhan, et al.
Publicado: (2023)

Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance
por: Nambasa, Victoria, et al.
Publicado: (2020)

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
por: Kiguba, Ronald, et al.
Publicado: (2020)

Factors associated with occupancy of pharmacist positions in public sector hospitals in Uganda: a cross-sectional study
por: Obua, Thomas Ocwa, et al.
Publicado: (2017)

An Evaluation of Antibiotic Prescribing Practices in a Rural Refugee Settlement District in Uganda
por: Bonniface, Matua, et al.
Publicado: (2021)

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
por: Zakumumpa, Henry, et al.
Publicado: (2021)

Compliance of private pharmacies in Uganda with controlled prescription drugs regulations: a mixed-methods study
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2020)

The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study
por: Ndagije, Helen Byomire, et al.
Publicado: (2018)

Cold chain management practices of non-vaccine commodities in public health facilities of Rwenzori Region, Western Uganda
por: Tumwine, Yona, et al.
Publicado: (2023)

Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
por: Kiguba, Ronald, et al.
Publicado: (2022)

Adverse Drug Reaction Onsets in Uganda’s VigiBase(®): Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses
por: Kiguba, Ronald, et al.
Publicado: (2018)

Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study
por: Kiguba, Ronald, et al.
Publicado: (2022)

Supply-chain factors and antimicrobial stewardship
por: Kamere, Nduta, et al.
Publicado: (2023)

Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
por: Ndagije, Helen Byomire, et al.
Publicado: (2020)

Acceptability and feasibility of a mobile health application for enhancing public private mix for TB care among healthcare Workers in Southwestern Uganda
por: Tumuhimbise, Wilson, et al.
Publicado: (2023)

Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study
por: Zakumumpa, Henry, et al.
Publicado: (2022)

Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda
por: Ndagije, Helen, et al.
Publicado: (2015)

The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study
por: Ndagije, Helen Byomire, et al.
Publicado: (2019)

The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed
por: Younus, Manal M., et al.
Publicado: (2023)

Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report
por: Cohen, Sarit, et al.
Publicado: (2009)

Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022)

Ceftriaxone-induced hemolysis
por: Guleria, Vivek S., et al.
Publicado: (2013)

Ceftriaxone‐associated pseudolithiasis
por: Kurihara, Masaru, et al.
Publicado: (2021)

The 27 kDa Trypanosoma brucei Pentatricopeptide Repeat Protein is a G-tract Specific RNA Binding Protein
por: Kamba, Pakoyo F., et al.
Publicado: (2018)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Ceftriaxone–Associated Nephrolithiasis in Children
por: Fesharakinia, Azita, et al.
Publicado: (2013)

Resistance to ceftriaxone in Vibrio cholerae
por: Mandal, Jharna, et al.
Publicado: (2012)

Asymptomatic ceftriaxone‐associated pseudolithiasis
por: Sasaki, Osamu, et al.
Publicado: (2019)

Impact of Obesity on Ceftriaxone Efficacy †
por: Barber, Katie E., et al.
Publicado: (2020)

Ceftriaxone: Agranulocytosis: case report
Publicado: (2021)

Ceftriaxone-induced Acute Cholecystitis
por: Gomes, Fernanda Marta, et al.
Publicado: (2021)

Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy
por: Ricci, Susanna, et al.
Publicado: (2020)

The In Vitro Efficacy of Activated Charcoal in Fecal Ceftriaxone Adsorption among Patients Who Received Intravenous Ceftriaxone
por: Torvorapanit, Pattama, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_piqfikfjpibh52jl7054uautp3